Sheryl Zwerski
Overview
Explore the profile of Sheryl Zwerski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
588
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Theodore D, Neradilek M, Gillespie K, Edupuganti S, Hinojosa J, Lama J, et al.
J Acquir Immune Defic Syndr
. 2025 Feb;
98(4):340-345.
PMID: 39970314
Background: Realizing the potential of HIV prevention options requires understanding product tolerability across diverse groups vulnerable to HIV acquisition. Gender minority (GM) individuals are understudied in clinical trials. Setting: HVTN...
2.
Abrams E, Calmy A, Fairlie L, Mahaka I, Chimula L, Flynn P, et al.
J Int AIDS Soc
. 2022 Jul;
25 Suppl 2:e25916.
PMID: 35851757
Introduction: Women who are pregnant or who could become pregnant experience delayed access to or underinformed use of important new antiretroviral (ARV) drugs because of traditional drug development processes that...
3.
Greenwood G, Wilson A, Bansal G, Barnhart C, Barr E, Berzon R, et al.
AIDS Behav
. 2021 Apr;
26(Suppl 1):5-26.
PMID: 33886010
The National Institutes of Health (NIH) recognizes that, despite HIV scientific advances, stigma and discrimination continue to be critical barriers to the uptake of evidence-based HIV interventions. Achieving the Ending...
4.
Dawson L, Zwerski S
Bioethics
. 2014 Sep;
29(5):316-23.
PMID: 25230397
This article seeks to advance ethical dialogue on choosing standards of prevention in clinical trials testing improved biomedical prevention methods for HIV. The stakes in this area of research are...
5.
Fowler M, Coovadia H, Herron C, Maldonado Y, Chipato T, Moodley D, et al.
J Acquir Immune Defic Syndr
. 2013 Nov;
65(3):366-74.
PMID: 24189151
Background: HPTN 046 compared the efficacy and safety of infant nevirapine (NVP) among HIV-exposed breastfed infants randomized at 6 weeks to 6 months to t NVP or placebo to prevent...
6.
Shapiro R, Kitch D, Ogwu A, Hughes M, Lockman S, Powis K, et al.
AIDS
. 2013 Nov;
27(12):1911-20.
PMID: 24180000
Objectives: HAART for prevention of mother-to-child HIV transmission (MTCT) may impact long-term survival of women and children. Design: Randomized clinical trial. Methods: HIV-infected pregnant women with CD4+ cell count at...
7.
Watts D, Brown E, Maldonado Y, Herron C, Chipato T, Reddy L, et al.
J Acquir Immune Defic Syndr
. 2013 Jul;
64(3):299-306.
PMID: 23846568
Background: Starting lifelong antiretroviral therapy (ART) in HIV-infected pregnant women may decrease HIV progression and transmission, but adherence after delivery may be difficult, especially for asymptomatic women. We evaluated disease...
8.
Fogel J, Mwatha A, Richardson P, Brown E, Chipato T, Alexandre M, et al.
Pediatr Infect Dis J
. 2012 Dec;
32(4):e164-9.
PMID: 23249916
Background: The HIV Prevention Trials Network (HPTN) 046 trial evaluated the efficacy of extended infant nevirapine (NVP) administration for prevention of HIV transmission through breastfeeding. Infants received daily NVP up...
9.
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, et al.
J Acquir Immune Defic Syndr
. 2012 Dec;
63(1):1-8.
PMID: 23221981
Background: The development of a safe and effective vaccine against HIV type 1 for the prevention of mother-to-child transmission of HIV would significantly advance the goal of eliminating HIV infection...
10.
Coovadia H, Brown E, Fowler M, Chipato T, Moodley D, Manji K, et al.
Lancet
. 2011 Dec;
379(9812):221-8.
PMID: 22196945
Background: Nevirapine given once-daily for the first 6, 14, or 28 weeks of life to infants exposed to HIV-1 via breastfeeding reduces transmission through this route compared with single-dose nevirapine...